Identification of differential DNA methylation alterations of ovarian cancer in peripheral whole blood based on within-sample relative methylation orderings
收藏Figshare2021-03-22 更新2026-04-28 收录
下载链接:
https://figshare.com/articles/dataset/Identification_of_differential_DNA_methylation_alterations_of_ovarian_cancer_in_peripheral_whole_blood_based_on_within-sample_relative_methylation_orderings/14260192
下载链接
链接失效反馈官方服务:
资源简介:
Leukocyte cell proportion changes affect the detection of cancer-associated aberrant DNA methylation alterations in peripheral blood samples. We aimed to detect cellular DNA methylation changes in ovarian cancer (OVC) blood samples avoiding the above-mentioned cell-composition effects. Based on the within-sample relative methylation orderings (RMOs) of CpG loci in leukocyte subtypes, we developed the Ref-RMO method to detect aberrant methylation alterations from OVC blood samples. Stable CpG pairs with consistent RMOs in different leukocyte subtypes were determined, more than 99% of which retained their RMO patterns in peripheral whole blood (PWB) in independent datasets. Based on the stable CpG pairs, significantly reversed CpG pairs were detected from OVC PWB samples, which were relative to clinical information such as age, subtype, grade, stage, or CA125 level. Results showed 439 CpG loci were determined to be significant differential DNA methylations between OVC and healthy blood samples. They were mainly enriched in KEGG pathways, such as cytokine-cytokine receptor interaction, apoptosis, proteoglycans in cancer, and immune-associated Gene Ontology terms. STRING analysis showed that they tended to have functional interactions with cancer-associated genes recorded in the COSMIC database. Leukocyte cellular differential DNA methylations could be identified by the proposed RMO-based method from OVC PWB samples, which were cancer-associated aberrant signals against cell-composition effects.
白细胞比例变化会干扰外周血样本中癌症相关异常DNA甲基化改变的检测。本研究旨在规避上述细胞组成带来的混杂效应,检测卵巢癌(OVC)患者血液样本中的细胞DNA甲基化变化。基于不同白细胞亚型中CpG位点(CpG loci)的样本内相对甲基化排序(RMOs),我们开发了Ref-RMO方法,用于从OVC患者外周血样本中鉴定异常甲基化改变。我们筛选出在多种白细胞亚型中相对甲基化排序保持一致的稳定CpG对,其中超过99%的稳定CpG对在独立数据集的外周全血(PWB)中仍维持其RMO模式。基于这些稳定CpG对,我们从OVC患者外周全血样本中检测到显著反向的CpG对,这类CpG对与患者年龄、亚型、分级、分期及CA125水平等临床信息存在显著关联。研究结果显示,共鉴定出439个在OVC患者与健康对照血液样本间存在显著差异的DNA甲基化位点。这些位点主要富集于细胞因子-细胞因子受体相互作用、细胞凋亡、癌症相关蛋白聚糖等京都基因与基因组百科全书(KEGG)通路,以及免疫相关基因本体(GO)术语。STRING数据库分析表明,这些位点倾向于与癌症体细胞突变目录(COSMIC)数据库收录的癌症相关基因存在功能互作。本研究提出的基于RMO的方法可从OVC患者外周全血样本中鉴定出白细胞源性差异DNA甲基化,这类甲基化变化属于对抗细胞组成干扰的癌症相关异常信号。
创建时间:
2021-03-22



